X
ASG Eye Hospital

₹0.00

mrf 0.00%
13 Nov 4:01 p.m.

Listing Status:

Connect: •••
•••• ••••
•••
Key Metrics of ASG Eye Hospitals
  • Market Cap
  • Total Equity Funding ₹2,161 Cr in 7 rounds
  • Latest Funding Round ₹1,500 Cr, Series D Jul 27, 2022
  • Post Money Valuation ₹3,544 Cr as on Jan 15, 2025
  • Annual Revenue ₹1,145 Cr
    ▲ 39% YoYas on Mar 31, 2025
  • EBITDA ₹273 Cr
    ▲ 37% YoYas on Mar 31, 2025
  • EBITDA Margin 23.85%
    ▼ 2% YoYas on Mar 31, 2025
  • Net Profit ₹78 Cr (Loss)
    ▼ 4% YoYas on Mar 31, 2025
  • Net Profit Margin -6.81%
    ▲ 25% YoYas on Mar 31, 2025
About the Company

Chain of super specialty eye care hospitals. It offers a range of ophthalmology services, including cataract surgery, diabetic retinopathy treatment,...

Loading...
Price on BSE Volume

Funding Rounds

Total Rounds: 7 Asgeyehospital

S.No. Date Round Name Amount TTM Revenue Investors & Facilitators
1. Jul 27, 2022 Series D ₹1,500 Cr ₹333 Cr
Inst: General Atlantic, Kedaara, Foundation Holdings, Skyvision, Britten Holdings, Massive Impacts
Angel: Shilpi, Arun
Facil: Khaitan
2. Apr 29, 2020 Series C ₹40 Cr ₹144 Cr
Inst: Britten Holdings, Care Holdings
3. Dec 10, 2019 Series C ₹110 Cr ₹140 Cr
Inst: Care Holdings, Britten Holdings
4. Sep 18, 2019 Series C ₹306 Cr ₹137 Cr
Inst: Foundation Holdings, Symphony International Holdings
5. Oct 4, 2017 Series B ₹65 Cr ₹102 Cr
Inst: Investcorp
6. Sep 4, 2017 Series B ₹75 Cr ₹100 Cr
Inst: IDFC Alternatives
Facil: Allegro Advisors
7. Jan 15, 2013 Series A ₹64 Cr -
Inst: Sequoia Capital

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25
FY 23-24
FY 22-23
FY 21-22
FY 20-21
FY 19-20
FY 18-19
FY 17-18
FY 16-17
FY 15-16
FY 14-15
FY 13-14
Detailed Income StatementFY 24-25 (in Cr)
1,145.1
1,219.1
Total profit before exceptional items, extraordinary items and tax (74.0)
Exceptional items before tax (10.6)
Total profit before tax (84.6)
(6.5)
Total profit (loss) for period from continuing operations (78.0)
Total profit (loss) for period (78.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 24-25 (in Cr)
2,722.6
2,722.6
Detailed Cash Flow StatementFY 24-25 (in Cr)
Net cash from / (used in) operating activities 170.5
Net cash from / (used in) investing activities (223.7)
Net cash from / (used) in financing activities 183.4
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 130.3
Net increase / (decrease) in cash and cash equivalents 130.3
Cash and cash equivalents at the beginning of the year 30.2
Cash and cash equivalents at the end of the year 160.5
Detailed Income StatementFY 23-24 (in Cr)
823.2
888.8
Total profit before exceptional items, extraordinary items and tax (65.6)
Exceptional items before tax 0
Total profit before tax (65.6)
9.2
Total profit (loss) for period from continuing operations (74.8)
Total profit (loss) for period (74.8)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 23-24 (in Cr)
2,331.3
2,331.3
Detailed Cash Flow StatementFY 23-24 (in Cr)
Net cash from / (used in) operating activities 114.4
Net cash from / (used in) investing activities (380.0)
Net cash from / (used) in financing activities 197.6
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (68.0)
Net increase / (decrease) in cash and cash equivalents (68.0)
Cash and cash equivalents at the beginning of the year 98.2
Cash and cash equivalents at the end of the year 30.2
Detailed Income StatementFY 22-23 (in Cr)
456.1
437.1
Total profit before exceptional items, extraordinary items and tax 19.0
Total profit before tax 19.0
8.3
Total profit (loss) for period from continuing operations 10.7
Total profit (loss) for period 10.7
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 22-23 (in Cr)
1,587.3
1,587.3
Detailed Cash Flow StatementFY 22-23 (in Cr)
Net cash from / (used in) operating activities 186.0
Net cash from / (used in) investing activities (819.2)
Net cash from / (used) in financing activities 723.5
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 90.3
Net increase / (decrease) in cash and cash equivalents 90.3
Cash and cash equivalents at the beginning of the year 8.0
Cash and cash equivalents at the end of the year 98.2
Detailed Income StatementFY 21-22 (in Cr)
270.9
862.1
Total profit before exceptional items, extraordinary items and tax (591.2)
Total profit before tax (591.2)
(2.9)
Total profit (loss) for period from continuing operations (588.3)
Total profit (loss) for period (588.3)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 21-22 (in Cr)
577.5
577.5
Detailed Cash Flow StatementFY 21-22 (in Cr)
Net cash from / (used in) operating activities 43.6
Net cash from / (used in) investing activities (117.6)
Net cash from / (used) in financing activities 60.3
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (13.7)
Net increase / (decrease) in cash and cash equivalents (13.7)
Cash and cash equivalents at the beginning of the year 20.6
Cash and cash equivalents at the end of the year 6.9
Detailed Income StatementFY 20-21 (in Cr)
149.4
162.1
Total profit before prior period items, exceptional items, extraordinary items and tax (12.8)
Exceptional items before tax 0
Total profit before extraordinary items and tax (12.8)
Total profit before tax (12.8)
(2.1)
Total profit (loss) for period from continuing operations (10.7)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period before minority interest (10.7)
Profit (loss) of minority interest 0
Share of profit (loss) of associates 0
Total profit (loss) for period (10.7)
Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations 0
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Nominal value of per equity share 0.0
Detailed Balance SheetFY 20-21 (in Cr)
292.2
292.2
Detailed Cash Flow StatementFY 20-21 (in Cr)
Cash flow from operating activities 21.9
Net cash from / (used in) operating activities 21.9
Cash flow from investing activities (56.2)
Net cash from / (used in) investing activities (56.2)
Cash flow from financing activities 44.8
Net cash from / (used) in financing activities 44.8
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 10.5
Effect of exchange rate changes on cash and cash equivalents (0.0)
Net increase / (decrease) in cash and cash equivalents 10.4
Cash and cash equivalents at the beginning of the year 10.2
Cash and cash equivalents at the end of the year 20.6
Detailed Income StatementFY 19-20 (in Cr)
143.8
147.6
Total profit before prior period items, exceptional items, extraordinary items and tax (3.8)
Exceptional items before tax 0
Total profit before extraordinary items and tax (3.8)
Total profit before tax (3.8)
(1.0)
Total profit (loss) for period from continuing operations (2.8)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period before minority interest (2.8)
Profit (loss) of minority interest 0
Share of profit (loss) of associates 0
Total profit (loss) for period (2.8)
Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations 0
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Nominal value of per equity share 0.0
Detailed Balance SheetFY 19-20 (in Cr)
244.6
244.6
Detailed Cash Flow StatementFY 19-20 (in Cr)
Cash flow from operating activities 18.2
Net cash from / (used in) operating activities 18.2
Cash flow from investing activities (70.1)
Net cash from / (used in) investing activities (70.1)
Cash flow from financing activities 57.7
Net cash from / (used) in financing activities 57.7
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 5.9
Effect of exchange rate changes on cash and cash equivalents (0.1)
Net increase / (decrease) in cash and cash equivalents 5.8
Cash and cash equivalents at the beginning of the year 4.4
Cash and cash equivalents at the end of the year 10.2
Detailed Income StatementFY 18-19 (in Cr)
129.8
121.2
Total profit before prior period items, exceptional items, extraordinary items and tax 8.6
Exceptional items before tax 0
Total profit before extraordinary items and tax 8.6
Total profit before tax 8.6
(3.7)
Total profit (loss) for period from continuing operations 12.3
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period before minority interest 12.3
Profit (loss) of minority interest 0
Share of profit (loss) of associates 0
Total profit (loss) for period 12.3
Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations 0
Basic earning per equity share before extraordinary items 0.0
Diluted earnings per equity share before extraordinary items 0.0
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Nominal value of per equity share 0.0
Detailed Balance SheetFY 18-19 (in Cr)
177.6
177.6
Detailed Cash Flow StatementFY 18-19 (in Cr)
Cash flow from operating activities 14.7
Net cash from / (used in) operating activities 14.7
Cash flow from investing activities (56.9)
Net cash from / (used in) investing activities (56.9)
Cash flow from financing activities (7.1)
Net cash from / (used) in financing activities (7.1)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (49.3)
Effect of exchange rate changes on cash and cash equivalents (0.4)
Net increase / (decrease) in cash and cash equivalents (49.7)
Cash and cash equivalents at the beginning of the year 54.1
Cash and cash equivalents at the end of the year 4.4
Detailed Income StatementFY 17-18 (in Cr)
110.0
103.4
Total profit before prior period items, exceptional items, extraordinary items and tax 6.6
Exceptional items before tax (1.0)
Total profit before extraordinary items and tax 5.6
Total profit before tax 5.6
0.0
Total profit (loss) for period from continuing operations 5.5
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period before minority interest 5.5
Profit (loss) of minority interest 0
Share of profit (loss) of associates 0
Total profit (loss) for period 5.5
Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations 0
Basic earning per equity share before extraordinary items 0.0
Diluted earnings per equity share before extraordinary items 0.0
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Nominal value of per equity share 0.0
Detailed Balance SheetFY 17-18 (in Cr)
168.0
168.0
Detailed Cash Flow StatementFY 17-18 (in Cr)
Cash flow from operating activities 14.6
Net cash from / (used in) operating activities 14.6
Cash flow from investing activities (39.3)
Net cash from / (used in) investing activities (39.3)
Cash flow from financing activities 74.2
Net cash from / (used) in financing activities 74.2
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 49.5
Effect of exchange rate changes on cash and cash equivalents (0.0)
Net increase / (decrease) in cash and cash equivalents 49.5
Cash and cash equivalents at the beginning of the year 4.5
Cash and cash equivalents at the end of the year 58.9
Detailed Income StatementFY 16-17 (in Cr)
89.6
85.3
Total profit before prior period items, exceptional items, extraordinary items and tax 4.3
Exceptional items before tax 0
Total profit before extraordinary items and tax 4.3
Total profit before tax 4.3
0.0
Total profit (loss) for period from continuing operations 4.3
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period before minority interest 4.3
Profit (loss) of minority interest 0
Share of profit (loss) of associates 0
Total profit (loss) for period 4.3
Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations 0
Basic earning per equity share before extraordinary items 0.0
Diluted earnings per equity share before extraordinary items 0.0
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Nominal value of per equity share 0.0
Detailed Balance SheetFY 16-17 (in Cr)
81.9
81.9
Detailed Cash Flow StatementFY 16-17 (in Cr)
Cash flow from operating activities 5.4
Net cash from / (used in) operating activities 5.4
Cash flow from investing activities (8.2)
Net cash from / (used in) investing activities (8.2)
Cash flow from financing activities (0.2)
Net cash from / (used) in financing activities (0.2)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (3.1)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase / (decrease) in cash and cash equivalents (3.1)
Cash and cash equivalents at the beginning of the year 7.6
Cash and cash equivalents at the end of the year 7.4
Detailed Income StatementFY 15-16 (in Cr)
54.8
65.1
Total profit before prior period items, exceptional items, extraordinary items and tax (10.4)
Exceptional items before tax 0
Total profit before extraordinary items and tax (10.4)
Total profit before tax (10.4)
0
Total profit (loss) for period from continuing operations (10.4)
Detailed Balance SheetFY 15-16 (in Cr)
72.0
72.0
Detailed Cash Flow StatementFY 15-16 (in Cr)
Detailed Income StatementFY 14-15 (in Cr)
43.9
55.0
Total profit before prior period items, exceptional items, extraordinary items and tax (11.1)
Exceptional items before tax 0
Total profit before extraordinary items and tax (11.1)
Extraordinary items before tax 0
Total profit before tax (11.1)
(0.1)
Total profit (loss) for period from continuing operations (11.0)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (11.0)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 14-15 (in Cr)
51.5
51.5
Detailed Cash Flow StatementFY 14-15 (in Cr)
Detailed Income StatementFY 13-14 (in Cr)
26.8
44.0
Total profit before prior period items, exceptional items, extraordinary items and tax (17.1)
Exceptional items before tax 0
Total profit before extraordinary items and tax (17.1)
Total profit before tax (17.1)
0.1
Total profit (loss) for period from continuing operations (17.3)
Detailed Balance SheetFY 13-14 (in Cr)
49.9
49.9
Detailed Cash Flow StatementFY 13-14 (in Cr)

Shareholding Pattern

As of Jun 30, 2025 • Asgeyehospital

Total Shares 22.90M

Top Shareholders

Shareholder Category Shares (Mn) % Holding
General Atlantic Singapore ASGH Pte Ltd Fund 6.92M 30.22%
Kedaara Capital Fund III Llp Fund 4.61M 20.15%
Arun Singhvi Founder 3.63M 15.86%
Britten Holdings Enterprise 2.12M 9.26%
Sky Capitalvision Fund I Fund 1.87M 8.18%
Others

    Top Competitors

    Similar companies to Asgeyehospital

    Dr. Agarwal's Eye Hospital

    dragarwal.com

    Centre for Sight

    centreforsight.net

    Sharp Sight Eye Hospitals

    sharpsight.in

    Vasan Eye Care

    vasaneye.com

    Maxivision Eye Hospital

    maxivisioneyehospital.com

    Eye-Q

    eyeqindia.com
    No recent news
    Need help? Chat with us! WhatsApp